title: Management of oral anticoagulation in patients undergoing minor dental procedures.
abstract: Approximately 4.2 million patients in the United States are taking warfarin, making it the 11th most prescribed drug. Warfarin is primarily used for treatment of venous thromboembolic disease and stroke prevention in patients with atrial fibrillation and mechanical heart valves. Dentists frequently encounter anticoagulated patients and are faced with management decisions in these patients who require dental procedures. Observational studies suggest the risk of thrombosis if anticoagulation is suspended during dental procedures is higher than the risk of bleeding if anticoagulation is not suspended. Several groups now offer guidelines that recommend most minor dental procedures should be performed while on therapeutic warfarin. The recent approval of several new oral anticoagulants has introduced greater complexity to the management of the anticoagulated patient, and this narrative review will discuss current guidelines, the scientific underpinnings of the guidelines, and offer some practical suggestions for patients that are receiving the new agents.
authors.affiliation: Arabian Gulf University, Kingdom of Bahrain.
authors.forename: Yathreb
authors.initials: Y
authors.lastname: Alaali
authors.forename: Geoffrey D
authors.initials: GD
authors.lastname: Barnes
authors.forename: James B
authors.initials: JB
authors.lastname: Froehlich
authors.forename: Scott
authors.initials: S
authors.lastname: Kaatz
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D003752:Dental Health Services; D017408:Guidelines as Topic; D006487:Hemostasis; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000925:Anticoagulants